Bhuvana Lakkasetter Chandrashekar

Bhuvana Lakkasetter Chandrashekar

Auto-generated profile, based on publicly available information

Bhuvana Lakkasetter Chandrashekar

Department of Bioengineering, The University of Texas at Dallas, Richardson, TX, USA; School of Podiatric Medicine, The University of Texas Rio Grande Valley, Harlingen, TX, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2025 in Gels
Verified
Journal Article
Open access
PDF file
ILIsmael Lamas
Ismael Lamas
BCBhuvana L. Chandrashekar
Bhuvana L. Chandrashekar
Cláudia Cristina BiguettiCláudia Cristina Biguetti
Cláudia Cristina Biguetti
MIMOHAMMAD ISLAM
MOHAMMAD ISLAM
Soft tissues exhibit remarkable stretchability, fracture toughness, and stress–relaxation ability. They possess a large water content to support cellular processes. Mimicking such a combination of mechanical and physical properties in hydrogels is important for tissue engineering applications but remains challenging. This work aims to develop a hydrogel that can combine excellent mechanical properties with cellular viability. The research focused on polyvinyl alcohol (PVA)/agar double-network (DN) hydrogels, fabricated by thermal gelation and freeze–thawing methods. Their mechanical properties were characterized through tension, compression, fracture, and stress–relaxation tests, and their cellular viability was measured through cytotoxicity tests. The results show that the PVA/agar DN gels are highly stretchable (>200%) and compressible (>30%) while containing high water content. The incorporation of agar by 6 wt% improved the fracture toughness of hydrogels from 1 to 1.76 kJ/m2. The degree of stress–relaxation, a key indicator of gel viscoelastic properties, improved by roughly 170% with an increase in agar content from 0 to 6 wt%. Cytotoxicity analysis showed that the gels, being physically cross-linked, were able to promote cellular proliferation. This work shows that tough and viscoelastic PVA/agar DN gels are suitable for soft tissue engineering applications, especially cartilage repair.

9 May 2023 in The Journal of Foot and Ankle Surgery
Verified
Journal Article
Open access
AAAlexandra Arteaga
Alexandra Arteaga
CBClaudia Cristina Biguetti
Claudia Cristina Biguetti
BCBhuvana Lakkasetter Chandrashekar
Bhuvana Lakkasetter Chandrashekar
JMJimena Mora
Jimena Mora
AQAdeena Qureshi
Adeena Qureshi
DRDanieli C Rodrigues
Danieli C Rodrigues
There is a higher risk of implant osseointegration failure after open reduction and internal fixation (ORIF) in patients with diabetes due to increased inflammatory conditions, associated metallic corrosion and infection. While it is possible to avoid elective osseous surgery in patients with diabetes, it may not be the case in nonelective cases, such as ORIF ankle fractures. A total of 30 male Lewis rats (12-15 weeks old) were distributed into diabetic (D) and nondiabetic (ND) groups. Fracture healing and osseointegration were evaluated at 2-, 10-, and 21-day time points. Microtomographic and histological analysis depicted distinct differences in fracture healing and osseointegration between D and ND animals. Immunohistochemical analysis exhibited elevated proliferation (PCNA) and osteogenic (Runx2) cells for ND animals, while HMGB1 (inflammatory marker) was elevated for D animals during healing. Bone resorption marker CTX-1 was elevated in the plasma of D animals at 2 days, while bone formation marker P1NP was higher for ND animals at 10 days. Overall, this model resulted in delayed implant osseointegration and fracture healing in diabetic animals, highlighting the importance of developing new biomaterials or implant coatings that can improve bone healing outcomes in this patient population.

1 October 2025 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Closed access
DSDanyal A. Siddiqui
Danyal A. Siddiqui
SNSmriti G. Natarajan
Smriti G. Natarajan
BCBhuvana Lakkasetter Chandrashekar
Bhuvana Lakkasetter Chandrashekar
DRDanieli C Rodrigues
Danieli C Rodrigues

6 October 2025 in Odontology
Verified
Journal Article
Closed access
PDF file
BCBhuvana Lakkasetter Chandrashekar
Bhuvana Lakkasetter Chandrashekar
ARAnthony A. Reyes
Anthony A. Reyes
Cláudia Cristina BiguettiCláudia Cristina Biguetti
Cláudia Cristina Biguetti
DRDanieli C Rodrigues
Danieli C Rodrigues

1 January 2025 in Journal of Applied Oral Science
Verified
Journal Article
Open access
BCBhuvana Lakkasetter Chandrashekar
Bhuvana Lakkasetter Chandrashekar
AAAlexandra Arteaga
Alexandra Arteaga
EREvelin Rios
Evelin Rios
JMJimena Mora
Jimena Mora
GGGustavo Garlet
Gustavo Garlet
Cláudia Cristina BiguettiCláudia Cristina Biguetti
Cláudia Cristina Biguetti
Diabetes significantly impairs bone healing via several mechanisms, including sustained inflammation, oxidative stress, and poor osteogenic responses. Fully reduced isoform of High Mobility Group Box 1 with three serine substitutions (3S-HMGB1) has shown regenerative properties while being resistant to oxidative degradation. Objective: This study evaluated the therapeutic potential of a single local injection of 3S-HMGB1 in early osseointegration under diabetic conditions in mice. Methodology: A total of 48 male 129/Sv mice (24 non-diabetic [ND], 24 diabetic [D]) received titanium implants following maxillary first molar extraction. ND and D mice (n:12) were injected with either saline (control) or 3S-HMGB1 (0.75 mg/kg) into the fresh extraction socket. Osseointegration was evaluated at 7 and 21 days post-implantation using microCT, histology (bone-to-implant contact [BIC] and birefringence), and immunohistochemistry for Runx2 and CXCR4. Results: ND controls exhibited early osteogenic activity, with a predominance of Runx2-positive cells at 7 days and successful osseointegration by 21 days. In contrast, D controls showed reduced numbers of Runx2-positive cells and markedly lower BV/TV, indicating compromised bone healing at 21 days. Treatment with 3S-HMGB1 resulted in significantly increased bone volume at the implant site in D animals (55.6±7.20% vs. 44.6±6.23%) and restored BIC from 44.9±9.32% (D controls) to 61.78±11.31% (D 3S-HMGB1), near ND levels (65.16±7.64%). Both ND and D groups treated with 3S-HMGB1 presented enhanced collagen organization. No significant differences were found in CXCR4 between groups; however, in D animals, a distinct peri-implant staining pattern suggested impaired recruitment despite preserved stem cell niches in the bone marrow. Conclusions: Collectively, our findings indicate that a single injection of redox-stable 3S-HMGB1 may represent a promising regenerative strategy to mitigate early implant failure in diabetes. Future studies should explore sustained delivery approaches to enhance long-term outcomes.